Galderma Investigational Site 8030 — Raleigh, North Carolina

Galderma Investigational Site 8030 is a clinical research site located in Raleigh, North Carolina, United States 27612.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Galderma Investigational Site 8030 has participated in 1 clinical trials.

Therapeutic areas: Moderate-to-Severe Atopic Dermatitis.

Sponsors: Galderma R&D.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Galderma Investigational Site 8030?

Galderma Investigational Site 8030 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Galderma Investigational Site 8030 conducted?

Galderma Investigational Site 8030 has 1 clinical trials on record. Their work covers Moderate-to-Severe Atopic Dermatitis.

Is Galderma Investigational Site 8030 accredited by Crixeo Health?

Galderma Investigational Site 8030 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Galderma Investigational Site 8030?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.